Hepatitis C-related liver cancer still underutilizes direct-acting antivirals.

Published Date: 22 Nov 2023

A research presented at The Liver Meeting, the annual meeting of the American Hepatocellular Carcinoma Society, found that direct-acting antiviral agents (DAAs) are still not used enough in patients with hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC).

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Breast Cancer Patients Living Longer Post-Medicaid Expansion

2.

Error on the MGUS-Autoimmune Disease Association.

3.

Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.

4.

The majority of cancer medications that receive expedited approval end up failing confirmatory trials.

5.

Unified Neuro/Psych Residency Program: New Proposal.


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot